Opinion|Videos|November 29, 2023
Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
Dr Sara M. Tolaney reviews the currently available treatment options for HER2-positive metastatic breast cancer and notes that many new HER2-targeting antibody-drug conjugates and bispecific antibodies are in development.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC
2
The Emotional Side of Cancer Care Beyond Medical Treatment
3
Beyond Statistics: Lessons in Mindset and Action from a Cancer Survivor
4
Cancer and Answering the Phone
5